Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes Mellitus

NCT01874483 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo
DRUG: BI 187004
DRUG: BI 187004
DRUG: BI 187004
DRUG: BI 187004
DRUG: BI 187004
DRUG: BI 187004
DRUG: BI 187004

Sponsor

Boehringer Ingelheim